Search results
Shark Tank India's Namita Thapar to make a whopping amount of around Rs 127cr from her brand's IPO...
The Times of India· 11 hours agoShark Tank India's Namita Thapar is to receive a whopping of around Rs 127 cr from her recent...
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 19 hours agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita...
Shark Tank fame Namita Thapar likely to make around Rs 127 crore through Emcure Pharmaceuticals IPO...
The Times of India· 2 days agoNamita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on ...
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 2 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...
Shark Tank India’s Namita Thapar discusses difficulties juggling work and personal life: ‘I have...
Pinkvilla· 5 days agoNamita Thapar has earned a huge fanbase after her appearance as a judge on Shark Tank India. In her...
Shark Tank India Judges under fire for alleged silence on copyright dispute; Report
Pinkvilla· 7 days agoShark Tank India has consistently captivated viewers with its innovative pitches and pioneering...
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 15 hours agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...
Shark Tank India's Judges' silence on D2C brand's social media ban raises questions; founders know...
The Times of India· 6 days agoAccording to media reports, this move follows Sony Pictures Entertainment India's (SPNI) copyright...
Namita Thapar may gain ₹127 crore in Emcure Pharma IPO
Hindustan Times· 2 days agoThrough the IPO, Namita Thapar will offload a partial stake of about 12.68 lakh shares under the...
Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of...
The Economic Times· 17 hours agoThe initial public offering (IPO) of Emcure Pharmaceuticals will open for subscription on Wednesday,...